The FDA says the device, designed to repair broken blood vessels to stem bleeding, showed a “clinically meaningful benefit.” ...
Attorney Simon Purnell of Griffin Purnell said he thinks the courts' view of preemption is a "fundamental misunderstanding of ...
Imricor is executing a modular review process with the FDA, whereby modules covering ... is involved due to the number of devices for which we are seeking approval simultaneously.
TCET is meant to expedite Medicare coverage for new medical devices once approved by the FDA. The program ... Oz agreed that ...
effective FDA review process that helps advance the medical technologies American patients depend on.” FDA staffers said entire teams of five or more medical device reviewers had been reinstated.
For years, medtech firms around the globe (and certainly European companies) introduced their products in Europe, which requires obtaining a CE ...
Almost a third of medical device adverse events (AEs) were reported by manufacturers later than the US Food and Drug Administration’s (FDA) required 30-day window across a three-year period ...
Imricor Medical Systems (ASX:IMR) – which has developed the world’s only MRI-compatible devices for ... the US Food and Drug Administration’s (FDA’s) premarket approval (PMA) process ...